肝硬化的病理过程与慢性肝损伤、肠道通透性增加、菌群易位、系统性炎症和肠肝轴代谢异常有关，肠道菌群可作为疾病进展、严重程度和治疗效果观察的微生态线索。该疾病若缺少连续风险观察，可能导致失代偿风险识别滞后、复查管理不连续、干预效果难以量化和慢性肝病管理负担增加。本数据研究可持续积累肝硬化进展和肠肝轴异常相关的微生态证据，帮助发现失代偿风险线索、优化复查管理，并为干预随访、慢性肝病队列建设和健康管理提供

浙江省数据知识产权登记平台2026-08-18 更新00

Multivariable logistic regression analysis for risk of cirrhosis.

肝硬化风险预测

Multivariable logistic regression analysis for risk of cirrhosis.

NIAID Data Ecosystem00

Table_1_Skeletal muscle mass index as a predictor of long-term cirrhosis onset in young non-cirrhotic males with acute-on-chronic liver failure.DOCX

肝硬化风险预测

肌肉质量与肝病预后

BackgroundThe relationship between skeletal muscle mass index (SMI) and cirrhosis incidence in patients with non-cirrhotic acute-on-chronic (ACLF) has not been clarified. This study aimed to assess th

NIAID Data Ecosystem10

Nonresponse to Interferon-α Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis

丙型肝炎治疗预后

肝硬化风险预测

BackgroundThe long-term consequences of unsuccessful interferon-α based hepatitis C treatment on liver disease progression and survival have not been fully explored.Methods and FindingsWe performed re

Figshare2016-01-18 更新00

Predictors of liver cirrhosis (liver stiffness >17.1 kPa).

资源简介：

相关数据集